The Pennant Group, Inc. $PNTG Shares Sold by Grandeur Peak Global Advisors LLC

Grandeur Peak Global Advisors LLC lessened its holdings in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 5.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 255,037 shares of the company’s stock after selling 13,622 shares during the period. Grandeur Peak Global Advisors LLC owned approximately 0.74% of The Pennant Group worth $7,613,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PNTG. State of Wyoming increased its position in The Pennant Group by 41.3% during the 1st quarter. State of Wyoming now owns 6,170 shares of the company’s stock valued at $155,000 after buying an additional 1,803 shares in the last quarter. ProShare Advisors LLC acquired a new position in shares of The Pennant Group during the second quarter valued at about $207,000. Belpointe Asset Management LLC purchased a new position in shares of The Pennant Group in the 2nd quarter valued at approximately $211,000. Police & Firemen s Retirement System of New Jersey boosted its stake in The Pennant Group by 13.7% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 7,922 shares of the company’s stock worth $236,000 after purchasing an additional 953 shares in the last quarter. Finally, Bosun Asset Management LLC acquired a new stake in The Pennant Group in the 1st quarter worth approximately $249,000. 85.88% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on PNTG. Wall Street Zen raised shares of The Pennant Group from a “hold” rating to a “buy” rating in a report on Monday, November 24th. Wells Fargo & Company raised The Pennant Group from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $29.00 to $31.00 in a research report on Tuesday, November 18th. Zacks Research raised The Pennant Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 20th. Stephens reiterated an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a research note on Thursday, October 9th. Finally, Royal Bank Of Canada raised their price objective on The Pennant Group from $34.00 to $39.00 and gave the stock an “outperform” rating in a research note on Monday, November 17th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $33.60.

The Pennant Group Price Performance

NASDAQ:PNTG opened at $27.71 on Friday. The firm’s fifty day moving average is $25.26 and its two-hundred day moving average is $25.76. The firm has a market cap of $958.32 million, a price-to-earnings ratio of 36.94, a PEG ratio of 2.24 and a beta of 1.39. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The Pennant Group, Inc. has a one year low of $21.18 and a one year high of $32.00.

The Pennant Group (NASDAQ:PNTG) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.01. The business had revenue of $229.04 million during the quarter, compared to analysts’ expectations of $221.96 million. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. Research analysts expect that The Pennant Group, Inc. will post 0.75 EPS for the current year.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.